Key statistics
On Wednesday, Novozymes A/S (NZM:DUS) closed at 57.00, -6.56% below its 52-week high of 61.00, set on Sep 01, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 56.00 |
|---|---|
| High | 57.00 |
| Low | 56.00 |
| Bid | 56.00 |
| Offer | 59.50 |
| Previous close | 56.50 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
| Annual div (ADY) | 0.8748 EUR |
|---|---|
| Annual div yield (ADY) | 1.55% |
| Div ex-date | Aug 31 2026 |
| Div pay-date | Sep 16 2026 |
Data delayed at least 15 minutes, as of Sep 16 2026 18:30 BST.
More ▼
Announcements
- Initiation of Novonesis’ share buyback program
- Novonesis to build next generation enzyme production facility in India
- Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
- Trading by management and close relations of management
- H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
- Interim report H1 2026
- Announcement of share buyback program
- Increased outlook for 2026
- Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities
- Trading by management and close relations of management
More ▼
